Skip to content
2000
Volume 6, Issue 13
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Unlike natural cannabinoids which belong to the 6aR - trans series, the synthetic dexanabinol (HU-211), a 6aS-trans enantiomer, does not have affinity toward cannabinoid receptors and is devoid of cannabimimetic activity. On the other hand, dexanabinol demonstrated significant neuroprotective properties which prompted its development as a therapeutic agent. We now present the extension of a series of 6aS-trans cannabinoids with novel derivatives, including water soluble derivatives and congeners of dexanabinol.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612003399446
2000-09-01
2025-05-04
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612003399446
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test